XML 31 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES
12 Months Ended
Sep. 30, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 9      INCOME TAXES

 

The following table summarizes the Company’s consolidated provision for U.S. federal, state and foreign taxes on income:   

          
   Fiscal 2022   Fiscal 2021 
Current:          
Federal  $   $ 
State   3,000     
Foreign        
           
Deferred:          
Federal   (224,000)   (506,000)
State   6,000    (47,000)
Foreign   (22,000)   (146,000)
 Deferred Income Tax Expense (Benefit)   (237,000)   (699,000)
Change in valuation allowance   240,000    699,000 
Income tax provision  $3,000   $ 

 

The deferred tax provision/(benefit) is the change in the deferred tax assets and liabilities representing the tax consequences of changes in the amounts of temporary differences, net operating loss carryforwards and changes in tax rates during the fiscal year. The Company’s deferred tax assets and liabilities are comprised of the following: 

          
   September 30, 
   2022   2021 
Deferred tax assets          
Net operating losses  $2,006,000   $2,093,000 
Share-based compensation   220,000    175,000 
Excess tax over book basis in inventory   101,000    43,000 
Reserves and other allowances   649,000    569,000 
Accrued compensation   70,000    15,000 
Interest expense limitation   48,000    40,000 
Other items   18,000    16,000 
Total deferred tax assets   3,112,000    2,951,000 
           
Deferred tax liabilities          
Depreciation   (12,000)   (18,000)
Prepaid expenses   (96,000)   (131,000)
Intangible assets   (178,000)   (216,000)
Total deferred tax liabilities   (286,000)   (365,000)
Valuation allowance   (2,826,000)   (2,586,000)
Net deferred tax assets  $   $ 

 

The Company recorded a provision for income taxes which includes net expense of $3,000 and $0 in Fiscal 2022 and 2021, respectively. The Fiscal 2022 expense of $3,000 is for state income tax expenses in states where net operating loss carryforwards (“NOLs”) were not available.

 

At September 30, 2022, the Company had available net NOLs for U.S. federal income tax purposes of $6,940,000 and NOLs for state income tax purposes of $978,000. NOLs generated prior to 2018 expire beginning in 2031 while NOLs generated after 2018 have an indefinite carryforward period. The NOLs result in a deferred tax asset of $1,680,000 with respect to U.S. federal income taxes and $40,000 with respect to state income taxes. In addition, at September 30, 2022, the Company had available NOLs for foreign income tax purposes of $1,569,000, resulting in a deferred tax asset of $283,000, expiring through 2028. Total net deferred tax assets, before valuation allowance, were $2,826,000 and $2,586,000 at September 30, 2022 and 2021, respectively. Undistributed earnings of the Company's foreign subsidiaries are considered permanently reinvested; therefore, in accordance with U.S. GAAP, no provision for U.S. federal or state income taxes would result. In Fiscal 2022, Forward Switzerland had a net loss for tax purposes of $45,000 and Forward UK had net income for tax purposes of $150,000.

 

At September 30, 2022, as part of its periodic evaluation of the necessity to maintain a valuation allowance against its deferred tax assets, and after consideration of all factors, including, among others, projections of future taxable income, current year NOL utilization and the extent of the Company's cumulative losses in recent years, the Company determined that, on a more likely than not basis, it would not be able to use remaining deferred tax assets, except with respect to the U.S. federal income taxes in the event the Company elects to effect repatriation of certain foreign source income of Forward Switzerland, which income is currently considered to be permanently reinvested and for which no U.S. tax liability has been accrued. Accordingly, the Company has determined to maintain a full valuation allowance against its net deferred tax assets. At September 30, 2022 and 2021, the valuation allowance was $2,826,000 and $2,586,000, respectively. In the future, the utilization of the Company's NOLs may be subject to certain change of control limitations. If the Company determines that it will be able to use some or all of its deferred tax assets in a future reporting period, the adjustment to reduce or eliminate the valuation allowance would reduce its income tax expense and increase after-tax income.

 

The significant elements contributing to the difference between the U.S. federal statutory tax rate and the Company’s effective tax rate are as follows:  

          
   Fiscal 2022   Fiscal 2021 
U.S. federal statutory rate   21.0%    21.0% 
State tax rate, net of federal benefit   3.0%    (8.3%)
Foreign rate differential   2.9%    (2.6%)
Tax return to provision adjustments   (1.9%)   (78.8%)
Effect of state tax rate change   (3.8%)   (7.8%)
Change in valuation allowance   (20.3%)   129.9% 
Permanent differences   (1.1%)   (53.4%)
           
Effective tax rate   (0.2%)   0.0% 

 

In December 2020, the Company received approval of its application for forgiveness of its note payable related to the Paycheck Protection Program (the “PPP loan”) in the aggregate principal amount of $1,357,000, which was not recognized as taxable income pursuant to the CARES Act. Pursuant to the Consolidated Appropriations Act, 2021, which was enacted by Congress and signed into law by the President on December 27, 2020, all expenses utilizing funds from PPP loans will be deductible against taxable income.

 

At September 30, 2022 and 2021, the Company had not accrued any interest or penalties related to uncertain tax positions. It is the Company's policy to recognize interest and/or penalties, if any, related to income tax matters in income tax expense in the consolidated statements of operations. For the periods presented in the accompanying consolidated statements of operations, no material income tax related interest or penalties were assessed or recorded. All fiscal years prior to the fiscal year ended September 30, 2019 are closed to federal and state examination.